Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The FDA approved Addyi. But was there a hidden agenda?

Shirie Leng, MD
Meds
September 1, 2015
Share
Tweet
Share

Ladies, the moment you have all been waiting for is here!  No, not affordable childcare.  Not equal pay for equal work. Not gun control.  Not abortion rights or paid maternity leave or a female majority in Congress or a constitutional ban on the words “chick lit.”  Girls, it is so much better than all that.  We got pink Viagra!

Flibanserin.  Catchy name.  Addyi for short.  Approved by the FDA for hypoactive sexual desire or, for clarification, inhibited sexual desire, sexual aversion, or sexual apathy.  The New York Times defines this disorder as follows:

Inhibited sexual desire refers to a low level of sexual interest.  A person with ISD will not start, or respond to their partner’s desire for, sexual activity.  It often occurs when one partner does not feel intimate or close to the other.  Communication problems, lack of affection, power struggles and conflicts, and not having enough time alone together are common factors.  ISD can also occur in people who’ve had a very strict upbringing concerning sex, negative attitudes toward sex, or traumatic sexual experiences.

No way.  You can take a pill for the disorder called Brought Up Baptist?  Here’s more:

Illnesses and some medications can also contribute to ISD, especially when they cause fatigue, pain, or general feelings of malaise.  Commonly overlooked factors include insomnia or lack of sleep, which can lead to fatigue.

Wait.  Is the problem that I have inhibited sexual desire or that I just want to go to sleep?

The FDA actually rejected Addyi twice, in 2010 and 2013.  The reasons cited included the fact that it doesn’t really work.  Women who took it didn’t experience an increase in desire on a daily basis, but did have one more “satisfying” sexual experience per month than the placebo group.  Plus, it has side effects, like low blood pressure, fainting, nausea, dizziness, and, hilariously, sleepiness.  And, it has a boxed warning that the drug should not be used by people who drink.  Which is problematic, to say the least.  But, no worries.  The pink Viagra can only be prescribed or dispensed by practitioners who have watched an online slide presentation and passed a test of their comprehension.  So, thank God for that thorough education at least.

So why did the FDA decide to approve Addyi this time?  Lobbying money.  Plus the deployment the biggest money word there is: sexism.  Some women’s groups have accused the FDA of sexism for not approving a women’s libido pill while sanctioning a men’s version.  Or rather, a few vocal women have.  Prominent Washington feminists, together with the (female) co-founder and CEO of Sprout Pharmaceuticals (the company that makes the pill), the president of the National Organization for Women, and the help of a public relations company, managed to convince some people in Washington that the FDA was being discriminatory.   A very effective social lobbying campaign sealed the deal.

What all these feminists have missed is the very sexist labeling of yet another normal human female function as a “disease.”  Men can get inhibited sexual desire, too, but no one is talking about that “problem.”  (Viagra, by the way, is not a libido enhancer.  It is an erection enhancer.)  All of this looks very much like a mirror image of the Victorian-era belief that women should, in the immortal, and paraphrased, words of Queen Victoria, “Lie back and think of England.”

Low sexual desire in women is, if it is a problem at all, a symptom, not a disease.  Some women don’t desire sex and are fine with it.  For everybody else it is a normal response to normal life problems.  But, hey.  Maybe there’s a pill for that too.

Shirie Leng, a former nurse, is an anesthesiologist who blogs at medicine for real.

Image credit: WJBK

Prev

When doctors pass the buck: The ugly side of a shift-work mentality

September 1, 2015 Kevin 26
…
Next

It's time for physicians to be leaders in corporate medicine

September 2, 2015 Kevin 33
…

Tagged as: Medications, OB/GYN

Post navigation

< Previous Post
When doctors pass the buck: The ugly side of a shift-work mentality
Next Post >
It's time for physicians to be leaders in corporate medicine

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Shirie Leng, MD

  • The choice between medicine and nursing

    Shirie Leng, MD
  • New technology might help us become more empathetic to others’ suffering

    Shirie Leng, MD
  • Does practice really make perfect?

    Shirie Leng, MD

Related Posts

  • The FDA was wrong about Aduhelm

    M. Bennet Broner, PhD
  • The hidden work of primary care

    Michelle Nall, MPH, ANP-BC
  • What the FDA forgets in the battle against e-cigarettes

    Charlene Gaw
  • The hidden curriculum of medicine

    Errin Weisman, DO
  • The hidden threat of the 80-hour resident workweek 

    Anonymous
  • Dementia patients want effective drugs. How will the FDA respond?

    Ron Louie, MD

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 6 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • Why male fertility needs to be part of every health conversation

      Hoag Memorial Hospital Presbyterian | Conditions
    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Inside human trafficking: a guide to recognizing and preventing it [PODCAST]

      The Podcast by KevinMD | Podcast
    • Graduating from medical school without family: a story of strength and survival

      Anonymous | Education
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
  • Recent Posts

    • How home-based AI can reduce health inequities in underserved communities [PODCAST]

      The Podcast by KevinMD | Podcast
    • Adriana Smith’s story: a medical tragedy under heartbeat laws

      Nicole M. King, MD | Physician
    • What if medicine had an exit interview?

      Lynn McComas, DNP, ANP-C | Conditions
    • Why U.S. health care pricing is so confusing—and how to fix it

      Ashish Mandavia, MD | Physician
    • From survival to sovereignty: What 35 years in the ER taught me about identity, mortality, and redemption

      Kenneth Ro, MD | Physician
    • When doctors forget how to examine: the danger of lost clinical skills

      Mike Stillman, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The FDA approved Addyi. But was there a hidden agenda?
6 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...